Apelin-13 Changes Shape in the Vial, and the Mass Says So

Few peptides of this size turn into something else without help. Apelin-13 does exactly that: it converts spontaneously into a stable second molecule seventeen daltons lighter than the first. Read a certificate for this material and the first question is which of the two it actually describes.

Two forms, two masses

The peptide is Gln-Arg-Pro-Arg-Leu-Ser-His-Lys-Gly-Pro-Met-Pro-Phe – the thirteen C-terminal residues of the apelin precursor protein. In free form it has a monoisotopic mass of 1549.83 Da and an average mass of 1550.85 Da, under CAS 217082-60-5.

Cyclize the N-terminal glutamine and you get the pyroglutamate form, written Pyr-1 apelin-13 or [Pyr1]apelin-13. Same thirteen residues, monoisotopic mass 1532.80 Da, average 1533.81 Da.

The ring closes by itself

A glutamine sitting at the N-terminus can attack its own backbone nitrogen, close into a five-membered ring, and expel ammonia. What is left is pyroglutamate, and the molecule is 17.03 daltons lighter for it.

The reaction runs unprompted in aqueous solution, picking up speed at neutral to slightly acidic pH and faster again at elevated temperature. Calling it a synthesis defect misses the point, and so does calling it degradation in the ordinary sense – it is simply a chemical property of any peptide beginning with glutamine, and apelin-13 is the standard illustration.

Of the two forms, the cyclized one is the more stable, since its N-terminus no longer carries a free amine available for further reaction. Material that starts out as the free peptide will therefore drift toward pyroglutamate while stored in solution.

Three things that must agree

A usable certificate lines up name, mass and chromatogram. The name should specify apelin-13 or [Pyr1]apelin-13. The mass should sit near 1550.9 or near 1533.8 to match. The chromatogram should be consistent with whichever form was declared.

When they conflict, the mass is generally the trustworthy element and the name is generally what got carried over from an earlier document. A quoted mass of 1533.8 under an apelin-13 heading describes the cyclized peptide regardless of the heading.

Two peaks a short retention distance apart, whose masses differ by seventeen daltons, indicate partial conversion. That is a genuine and frequent observation rather than an artifact.

Methionine 11 adds a second shift

There is a methionine in the sequence, carrying the usual oxidation liability: a plus-sixteen sulfoxide that elutes earlier and can appear during handling rather than during synthesis.

On a peptide already being tracked for a minus-seventeen conversion, that puts two mass shifts in play simultaneously. A species at 1549.8 minus 17 plus 16 ends up just one dalton from the unmodified parent. Untangling that calls for high-resolution measurement, or more practically for chromatography that separates the species before the detector ever sees them.

Basic residues, tailing, and the charge states

Two arginines, a lysine and a histidine, with no acidic residue apart from the C-terminal carboxyl, leave apelin-13 substantially positive at working pH. Tailing on silica-based columns follows predictably, and trifluoroacetic acid is the customary ion-pairing correction.

That same basicity makes the peptide ionize efficiently in positive-mode electrospray. The doubly protonated ion near m/z 776.4 and the triply protonated ion near m/z 517.9 usually dominate. In those charge states the seventeen dalton conversion registers as a shift of 8.5 and 5.7 m/z units respectively – which is precisely why deconvoluting to a neutral mass makes the comparison easier to read.

The number in the name is a residue count

Several fragments of different lengths come from the apelin precursor, and the figure in each name counts residues. Apelin-17 and apelin-36 reach further toward the N-terminus and weigh correspondingly more. They do not substitute for apelin-13, and their certificates are not comparable to its.

Every member of the family ends in the same C-terminal phenylalanine, so observing a C-terminal fragment in a mass spectrum does not on its own tell one family member from another.

What a confirmed lot shows

A declared form – free peptide or pyroglutamate – with a deconvoluted neutral mass that agrees with it. A chromatogram revealing whether both forms are present and in what ratio. And an understanding that the ratio is not fixed. A lot analyzed as the free peptide and then kept in solution will not remain that way, which argues for lyophilized storage rather than for doubting the certificate.

Related reading

Several modifications alter a peptide chemically while leaving its sequence intact, and terminal cyclization is one of them; the wider set appears in half-life and analog modifications. The underlying mass arithmetic is covered in monoisotopic versus average mass.